Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. by Draper, G. J. et al.
Br. J. Cancer (1992), 66, 211 219 © Macmillan Press Ltd., 1992
Patterns of risk of hereditary retinoblastoma and applications to genetic
counselling
G.J. Draper, B.M. Sanders, P.A. Brownbill & M.M. Hawkins
Childhood Cancer Research Group, Department ofPaediatrics, University ofOxford, Oxford, UK.
Summary A registry including information about nearly 1,600 cases of retinoblastoma diagnosed in Britain
has been created at the Childhood Cancer Research Group. Cases have been classified as 'old germ cell
mutation', 'new germ cell mutation' or 'sporadic non-hereditary'. For a population-based group of 918 cases
diagnosed between 1962 and 1985 we have calculated the proportions of unilateral/bilateral and hereditary/
non-hereditary cases. Bilateral cases represent 40% of the total number over this period; the proportion
known to be hereditary is 44%, a higher proportion than has been reported elsewhere. By following up
selected groups of cases, an estimate has been made of the proportions of siblings of retinoblastoma patients
and offspring of survivors from retinoblastoma who are themselves affected with the disease. Where there is no
previous family history, the risk for siblings of retinoblastoma patients of developing the disease is approx-
imately 2% if the disease in the affected child is bilateral and 1% if it is unilateral, assuming that there are no
other siblings; if there are unaffected siblings the risks for subsequent children are lower. Children of patients
with hereditary retinoblastoma have a one in two chance of carrying the germ cell mutation and for those who
are carriers the probability of developing retinoblastoma is very close to the accepted figure of 90% if the
parents have bilateral retinoblastoma but probably less if they have the unilateral form. For children of
patients not known to be carriers, the probability of developing retinoblastoma is estimated to be about I %,
considerably lower than the previously accepted figure of about 5%. Retinoblastoma kindreds consist mainly
of bilateral cases but there is evidence that some kindreds have a high proportion of unilateral cases. The ways
in which these findings may be used in conjunction with modern techniques of molecular biology for prenatal
and postnatal genetic counselling are discussed.
Although a rare tumour, comprising only about 3% of all
childhood cancers in Western countries, retinoblastoma is of
particular interest to geneticists and molecular biologists. It
affects about one in 20,000 children, and occurs in a
hereditary form in about 40% of cases. Previous studies have
suggested that a predisposing germ line mutation is inherited
from an affected parent in about 10% of cases and a new
germinal mutation acquired in a further 30%. The remaining
cases have sporadic unilateral retinoblastoma; a small pro-
portion of these do in fact have a germinal mutation and are
at risk for passing the disease to their children (Vogel, 1979).
The pattern of inheritance is that of a dominant gene,
though the mutated retinoblastoma gene behaves as a reces-
sive gene at the cellular level. The function of the wild type
allele Rb+ at the retinoblastoma locus appears to be to
maintain normal cellular growth control, i.e. it is a 'tumour
suppressor gene'. Deletion or mutation of both alleles at this
locus in a retinal cell can lead to retinoblastoma (Knudson,
1978; Murphree & Benedict, 1984; Dryja et al., 1986; Friend
et al., 1986). The hereditary form of retinoblastoma, which
occurs in families where there has been a germ cell mutation
of the Rb gene, is incompletely penetrant; about 10% of
carriers of the mutated gene do not develop retinoblastoma.
Non-hereditary retinoblastoma is caused by two mutations
to a somatic cell, and the patient is only affected unilaterally.
Patients with the hereditary form of retinoblastoma who
survive after treatment for the disease have a greatly in-
creased risk of developing second non-ocular neoplasms. In
adolescence, the risk is particularly high for osteosarcoma,
and the increased risk for other neoplasms has been shown to
continue in later life (Abramson et al., 1984; Draper et al.,
1986; Sanders et al., 1989).
Information about nearly 1,600 cases of retinoblastoma
ascertained by the Childhood Cancer Research Group
(CCRG) has been used to create a registry consisting of a
computer database of linked files from which information
can be abstracted to enable studies of selected groups of
cases and families to be carried out. Various sets of data
have been selected in order to study the risks that further
cases of retinoblastoma may develop in families with affected
children. In particular we have studied the risk that siblings
may be affected after the appearance of retinoblastoma in
one child in a family, and the risk for survivors from retino-
blastoma that their children will develop the disease.
Description of registry
Sources ofascertainment
The Childhood Cancer Research Group has been notified of
all cases of retinoblastoma registered through the National
Cancer Registration Scheme in Britain from 1962 onwards.
In addition, at certain centres of treatment for retinoblas-
toma, all patients treated in specified periods before 1962
have been ascertained. Death certificates for patients dying
from retinoblastoma in England and Wales since 1953 have
been received from the Office of Population Censuses and
Surveys and those for Scotland from the General Register
Office. Two interview studies were carried out on the above
patients as part of the Oxford Survey of Childhood Cancers:
one included children dying from retinoblastoma between
1953 and 1983 and the second included children registered
with the disease between 1962 and 1971. Parents of the
children were interviewed in these studies by medical staff
from local authority health departments and by family doc-
tors, and information was obtained relating to all aspects of
the illness and to any known family history of retinoblas-
toma. A further series of interviews was carried out with the
parents of children born between 1965 and 1985 attending
Moorfields Hospital and St Bartholomew's Hospital in Lon-
don for treatment or follow up after treatment for retinoblas-
toma. Complete pregnancy histories for the parents were
obtained in the course of these three interview studies. Sur-
viving patients have been followed up through hospital con-
sultants and family doctors and by 'flagging' at the National
Health Service Central Registers (NHSCR): for patients
flagged in this way, cancer registrations for any subsequent
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tumours and death certificates are received routinely from the
NHSCR.
In addition to the above groups of patients, all relatives of
index cases known to have had retinoblastoma or, by inspec-
tion of the pedigree, discovered to have been unaffected
carriers of the disease have been included in the registry.
Currently, 137 families with more than one case of retino-
blastoma are known to us. One family is known to include
19 patients with retinoblastoma.
Classification ofcases
We have used the following criteria to divide all cases into
three groups.
(i) Cases with a known family history of the disease either
in a previous generation or in a collateral family line or with
affected siblings have inherited a germ cell mutation probably
from at least two generations back. We have called these old
germ cell mutation cases.
(ii) Cases which are bilateral but have no previous known
family history are called new germ cell mutation cases; also in
this category we have placed those unilateral cases which
represent the first appearance of retinoblastoma in a family if
there is subsequently an affected child. We have assumed
here that the most likely explanation for the occurrence of
such cases is a germ cell mutation in an unaffected parent of
the index case.
(iii) The remaining unilateral cases with no known family
history of retinoblastoma are referred to as sporadic non-
hereditary cases. A small proportion of this last group may
subsequently be discovered to be hereditary because a child
of such a patient or some other family member develops
retinoblastoma.
Descriptive epidemiology andfamily studies
The following sections describe a series of three studies car-
ried out using information included in the registry. In the
next section we summarise information on a series of 918
cases of retinoblastoma diagnosed between 1962 and 1985.
These cases have been categorised by laterality and by wheth-
er or not there was a known family history of retinoblas-
toma. Mean and median ages at diagnosis have been cal-
culated for the separate groups. In the Section on Sibships of
retinoblastoma cases, information about affected and un-
affected siblings of retinoblastoma patients obtained during
interviews with their parents has been analysed to estimate
the risk that the sibling of an affected proband will develop
retinoblastoma. In the Section on Offspring of retinoblas-
toma cases, pregnancy histories of survivors from retinoblas-
toma obtained from questionnaires completed by their family
doctors have been analysed to estimate the risk that offspring
of these survivors will themselves develop retinoblastoma.
Incidence and age distributions for different types of
retinoblastoma
Table I includes 918 patients diagnosed between 1962 and
1985, the 24 years of national data for which we have almost
complete ascertainment. Cases are classified according to
their laterality and whether the retinoblastoma is hereditary
or non-hereditary. Altogether 364 patients, 40% of all cases,
were affected bilaterally. A total of 151 cases (16%) are
known to have inherited a mutation of the Rb gene because
there is a family history, and 255 cases (28%) with no known
family history are apparently caused by a new germ cell
mutation. Thus a total of 406 cases (44%) are known to be
hereditary; the remaining 512 cases (56%) are so far con-
sidered to be non-hereditary.
Table II shows the mean and median ages and age dis-
tribution at diagnosis for the cases in Table I. As has been
reported in previous studies (Leelawongs & Regan, 1968;
Matsunaga & Ogyu, 1976; Sanders et al., 1988) bilateral
cases tend to be diagnosed at a much younger age than
unilateral cases. For patients with an old germ cell mutation,
that is those with a family history, the mean age at diagnosis
for bilateral cases was 7.2 months, half of the cases being
diagnosed by 5 months; for unilateral cases in this group the
mean age at diagnosis was 20.3 months. The mean age at
diagnosis for sporadic unilateral cases was 29.5 months, half
of the cases being diagnosed by 26 months.
Sibships ofretinoblastoma cases
Methods
Information about 766 families of retinoblastoma patients,
ascertained during interviews with parents in the three inter-
view studies described above, was included in this study. A
complete pregnancy history for each family was obtained up
to the date the parents were interviewed. If any of the
siblings had developed retinoblastoma the laterality and date
of diagnosis were noted.
Results
The total numbers of liveborn children in the above families,
and the numbers affected by retinoblastoma are shown in
Table III. In this table and subsequent analyses the category
'previous family history' excludes those families where there
are sib pairs but no other affected relatives.
One of the objectives of the present paper is to determine,
in families where there was a child with retinoblastoma, the
risk that other children in the family would develop retino-
blastoma, and thus to produce information useful for genetic
counselling, based on a large number of families. Only
families with at least one liveborn child in addition to the
index child have been included in these analyses.
A total of 622 families with 1,905 live born children were
included in the analysis. In 34 of these families there was
more than one child with retinoblastoma: one family inclu-
ded three and one family four affected children. Two families
included monozygotic twins, both of whom developed retino-
blastoma; for the present analysis, each pair has been
counted as a single case of retinoblastoma.
The information from these 622 families has been used to
calculate the risks of retinoblastoma among the siblings of
affected children classified into groups according to whether
Table I Numbers ofretinoblastoma cases diagnosed between 1962 and 1985 subdivided
by laterality and by type of retinoblastoma
Non-
Year of Oldgerm cell mutation New germ cell mutation hereditary
diagnosis Bilateral Unilateral Bilateral Unilateral Unilateral Total
1962-1963 11 6 23 0 35 75
1964-1968 33 6 58 0 114 211
1969-1973 14 10 56 0 127 207
1974-1978 17 10 52 0 117 196
1979-1983 24 7 43 0 83 157
1984-1985 10 3 23 0 36 72
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Table II Age distribution and mean and median ages at first diagnosis for
retinoblastoma cases diagnosed between 1962 and 1985, subdivided by laterality and by
type of retinoblastoma
Age at Non-
diagnosis Old germ cell mutation New germ cell mutation hereditary
(months) Bilateral Unilateral Bilateral Unilateral Unilateral Total
0-5 64 12 61 0 28 165
6-11 23 4 70 0 63 160
12-17 11 9 51 0 55 126
18-23 5 3 31 0 75 114
24-29 3 3 19 0 78 103
30-35 0 2 13 0 62 77
36-41 0 2 5 0 46 53
42-47 2 1 1 0 30 34
48-53 0 1 1 0 28 30
54-59 0 1 1 0 11 13
60-119 0 3 1 0 34 38
120+ 0 0 1 0 2 3
Total 108 41 255 0 512 916
Mean age at 7.2 20.3 14.0 - 29.5 22.1
diagnosis
(months)
Median age at 5 15 11 - 26 18
diagnosis
(months)
Two children with hereditary retinoblastoma have been excluded from this table
because they presented with regressed tumours.
Table III Numbers ofliveborn children andcases ofretinoblastoma in families included
in the sibship study
Hereditary
Previousfamily No previous
history family history Non-hereditary Total
Children with bilateral 110 274 0 384
retinoblastoma
Children with unilateral 31 6 382 419
retinoblastoma
Unaffected siblings 81 467 698 1246
Total number of 222 747 1080 2049
live births
Live births 186 696 1023 1905
included in the analysis
Number of families 109 275 382 766
Number of families 73 224 325 622
included in the analysis
they had unilateral or bilateral retinoblastoma and to wheth-
er there was a family history of the disease in either a
previous generation or a collateral line; the method of
analysis adopted depends on whether there is known to be
such a mutation.
(i) Families where there is a previous family history For
these families the risk of retinoblastoma among the siblings
(excluding monozygous co-twins) is estimated (separately for
bilateral and unilateral probands) using standard actuarial
methods taking into account the length of follow-up, i.e. the
age of the sibling at the time of the interview with the family
or at the development of retinoblastoma or death from some
other cause. Families in which there is more than one
independently ascertained child with retinoblastoma (other
than monozygous twins) are included in the analysis more
than once, each child with an independent ascertainment
appearing in turn as the index child. This point is discussed
in the Appendix, Section A2.
The numbers of cases and the results of these calculations
are shown in Table IV which gives estimates of the pro-
bability of retinoblastoma developing among siblings, sub-
divided according to whether the proband is bilaterally or
unilaterally affected (The standard errors in this table may
be underestimated; see Appendix, Section A2.) The pro-
bability shown is the chance of a sibling developing the
disease by age 6 years. It is rare for retinoblastoma to
develop after 6 years, and in the present series no sibling
developed retinoblastoma after the age offour; thus these are
effectively the risks of ever developing retinoblastoma.
For siblings of bilaterally affected cases the probability of
retinoblastoma developing by age 6 years is 44.8%, which is
the figure normally quoted for the probability of retinoblas-
toma in families with the hereditary form of the disease
(45%); for siblings of unilaterally affected cases the corres-
ponding figure is 30%. The majority of cases have developed
by age 1 year. There is strong evidence from these data that
bilateral probands nearly always have bilateral siblings (47
out of 51 affected siblings being bilaterally affected) whereas
unilateral probands have unilateral siblings rather more fre-
quently than they have bilateral ones (seven out of 11).
(ii) Families where there is not a previousfamily history For
these families the estimation procedure has to allow for the
fact that there are in fact two groups, those with a previously
unrecognised germ cell mutation or gonadal mosaicism, and
those where the retinoblastoma in the offspring is due to a
somatic mutation or a mutation in just one parental germ
cell. In the first group of families it is quite likely that a
second child will be born with retinoblastoma whereas this is214 G.J. DRAPER et al.
Table IV Estimated probabilities of developing retinoblastoma for sibs of probands
where there is a previous family history
Estimated % ofsibs
No. ofsibsa No. ofaffected sibsa developing retinoblastoma by
Type ofproband at risk Bilateral Unilateral Total age 6years (standard error)
Bilateral 120 47 4 51 44.8 (5.3)
Unilateral 38 4 7 11 30.0 (9.0)
aInfamilieswithmorethanoneindependentlyascertainedproband,sibsarecountedmore
than once.
extremely unlikely for the second group.
The probability of a subsequent child being affected has to
be estimated (separately for bilateral and unilateral pro-
bands) taking into account the number of unaffected siblings
in the family. (It is assumed that there is only one affected
child; after a second affected sibling the family can be
assigned to the old germ cell mutation category).
The method of calculation is explained in Appendix Sec-
tion A3, and the results presented in Table V. For simplicity
we have given estimates, separately for bilateral and uni-
lateral probands, only for a second and fourth child born
into a family, i.e. for the case where the affected child is the
only child in the family and the case where there are also two
unaffected siblings. As can be seen from Table V the esti-
mated risk if there is just one affected case and no other
children in the family is about 2% for siblings of bilateral
cases and about 1% for siblings of unilateral cases. The
estimated risks are highest if the affected child is the only
child in the family and decrease as the number of unaffected
children increases: for the second case considered, i.e. where
in addition to the one affected child there are two unaffected
siblings, the estimated risks (i.e. for the fourth child in the
family) become about 0.6% if the affected child's retinoblas-
toma is bilateral and about 0.5% if it is unilateral. The
probabilities for other family sizes can be easily calculated
from that for families of size one as shown in Appendix
Section A3.
A measure of the precision of the estimates may be
obtained by regarding the number of sibships with a second
case as a Poisson variable. In this study there were two such
sibships for both the bilateral and the unilateral probands.
The 95% confidence limits for a Poisson mean when the
observed value is 2 are 0.24 and 7.2 and thus 95% lower and
upper confidence limits for each of the risk estimates given
above can be obtained by multiplying them by 0.12 and 3.6
respectively. For instance in families where there is just one
affected child (and no previous history of a germ cell muta-
tion) the lower and upper confidence limits for the risk that
the second child will be affected are about 0.2% and 7% if
the first child is a bilateral case, and 0.1% and 4% if it is
unilateral.
(iii) Other findings in the sibships It is interesting to note
that, in addition to the occurrence of retinoblastoma among
the siblings of these index children, two of the siblings of
sporadic cases of retinoblastoma developed non-ocular
cancer. One child was diagnosed with osteosarcoma aged 14
years, and the second developed acute lymphoblastic leu-
kaemia before he was two. In view of findings from many
previous reports about the relationship of the retinoblastoma
gene to other cancers (e.g. Sanders et al., 1989) it seems likely
that the first, and perhaps both, of these are examples of
cases in which the loss of the retinoblastoma gene does not
lead to retinoblastoma.
The numbers of miscarriages and stillbirths in these fam-
ilies were also studied to see whether there was any excess
risk of these events in the different categories of family.
There is some evidence that the mothers of children with
malignant disease tend to have a greater number of miscar-
riages than mothers in the general population. They are also
known to have a slightly increased chance of bearing another
child with cancer (Draper et al., 1977), and there are known
associations between childhood cancers and some congenital
abnormalities and genetic diseases. If, as seems likely, the
fetus in another pregnancy has an increased chance of mis-
carrying because of one of these conditions, this would ex-
plain the observed association. In retinoblastoma families it
is possible that parents carrying a germ cell mutation might
also have an increased history of miscarriages, while parents
of non-hereditary cases should have no increased risk. In the
present series there is no evidence of any difference in the risk
of miscarriage or stillbirth between the groups.
Offspring of retinoblastoma cases
Methods
A previous study of offspring of 1,348 survivors from cancer
born in 1962 or earlier included 263 retinoblastoma patients
(Hawkins et al., 1989). Questionnaires were sent to their
family doctors requesting information about the present
health of these patients, whether they had any liveborn chil-
dren, stillbirths, miscarriages, or terminations of pregnancy
and whether any of the children had developed retinoblas-
toma. One hundred and fifty-seven children were born to 89
of these patients. This study has now been extended and
up-dated, bringing the numbers for whom current infor-
mation about retinoblastoma survivors and their families has
been obtained up to 316. A further 36 questionnaires sent to
family doctors were not returned: there was thus an overall
90% positive response rate for the study.
Results
The numbers of known pregnancies, miscarriages, stillbirths
and liveborn children among female survivors and partners
of male survivors from retinoblastoma have been calculated
Table V Estimated probabilities of developing retinoblastoma for sibs of probands where there is not
known to be a previous family history
Estimated % ofsibs
developing retinoblastoma
No. ofaffected ifthere isjust one affected
Type of No. ofsibs sibs sib and
proband at risk Bilateral Unilateral Total (a) none unaffected (b) two unaffected
Bilateral 159 2 0 2 2.1a 0.6a
Unilateral 271 1 1 2 1.lb 0.5b
aAssuming a 90% penetrance in the subgroup of these families where there is a germ cell mutation. bAssuming a 60% penetrance in the subgroup of these families where there is a germ cell mutation.PATTERNS OF RISK OF HEREDITARY RETINOBLASTOMA 215
separately for parents classified as being old germ cell muta-
tion, new germ cell mutation and non-hereditary cases. A
total of 197 survivors were not known to have any livebom
children. (For 31 male survivors the family doctors stated
that they were not certain they would have known of any
children).
A total of 119 survivors had at least one liveborn child.
The families of 44 patients (15 males, 29 females) with
hereditary retinoblastoma included 78 children born before
the interview date, and 32 of them developed retinoblastoma:
26 children were affected bilaterally and six children unilat-
erally. There were two offspring with retinoblastoma among
the six children born to survivors of hereditary unilateral
retinoblastoma; these are included in the analysis, which is
based mainly on children born to survivors with bilateral
retinoblastoma. Three children (unaffected by retinoblas-
toma) who died within a few days of birth have been ex-
cluded from the analysis. The probabilities of retinoblastoma
occurring in the offspring of survivors from hereditary retin-
oblastoma by age 1 and 6 years have been calculated from
these data using the method described in the statistical
appendix, Section Al, and the results are shown in Table VI.
(The standard errors may be somewhat overestimated; see
Appendix A1.)
The probability of retinoblastoma occurring in children of
survivors of hereditary retinoblastoma - 43.5% by age 6
years - is, as with the sibship study, very close to the usually
quoted figure of 45%. We are also aware of five survivors
from bilateral retinoblastoma included in this survey who
had affected children and who have been excluded from the
analysis because details of these patients were not obtained
from their family doctors and information about their other
offspring was therefore not available. Of these, one question-
naire was not returned, two survivors had children who
developed retinoblastoma after the end of study date, and for
two survivors the family doctor did not know about the
affected children. These cases of retinoblastoma were notified
to us through cancer registries.
In addition to the offspring with retinoblastoma one child
of a patient with hereditary retinoblastoma developed a
malignant testicular teratoma.
It is particularly important to try to make some estimate of
the risk of retinoblastoma among the offspring of survivors
of sporadic unilateral retinoblastoma. Among 75 survivors
(34 males, 41 females) for whom questionnaires were re-
turned and who had offspring, 139 children were born before
the interview date and there were no affected cases among
these children. Among the 36 survivors included in the ques-
tionnaire study for whom no response was received, 24 were
sporadic unilateral cases, and it is possible that the infor-
mation on numbers of pregnancies and offspring was incor-
rect in a further 13 such cases where the family doctors may
not have had complete information. Thus for 37 patients, 22
males and 15 females, we do not know about the size of their
families, but it is reasonable to assume that we would know
about any affected offspring from cancer registration records
or other sources of ascertainment; we do in fact know
through cancer registration of one child with retinoblastoma
born to one of these female patients for whom no reply was
received from the family doctor. There were in total 165
completed questionnaires for the sporadic unilateral cases.
Assuming that the family sizes were similar for those from
whom no information is available we have estimated that the
numbers of families with 0, 1, 2, 3 . . . children were as
shown in Table VII. On the basis of these assumptions, and
assuming that all offspring are followed up to the age by
which any retinoblastomas would have appeared, we can
estimate the probability that a unilateral case with no family
history is in fact carrying a germ cell mutation, using the
method of maximum likelihood estimation as described in
the Appendix, Section A4. Assuming a penetrance of 90%
the estimated probability is about 1.7% with a standard error
also of 1.7%. If however, as suggested by Matsunaga (1978)
and der Kinderen (1987) the penetrance is lower for the
offspring of unilateral cases then the estimate of the propor-
tion of hereditary cases is higher. If we assume a penetrance
of 60% for the offspring of unilateral cases (in line with the
estimated risk of 30% to siblings of such cases found in
Table IV) this probability becomes 2.3% with a standard
error of 2.3%. In either case the estimated risk of retinoblas-
toma among the children of such patients is about 0.7%
-0.8%, with a standard error of the same magnitude.
TableVI Estimated probabilityofdevelopingretinoblastomaforoffspring ofparentswith
hereditary retinoblastoma
% ofoffspring developing
No. of No. ofaffected retinoblastoma by
survivors No. of offspring stated age (standard error)
with offspring offspring Bilateral Unilateral Total I year 6 years
44 75a 26 6 32 38.7 (5.6) 43.5 (7.0)
aThis total excludes three children (unaffected by retinoblastoma) who died within a few
days of birth.
Table VII Estimated family size distribution for 202 survivors of sporadic unilateral
retinoblastoma
Survivorsfor whom Estimate afor cases Estimatedfamily
No. of GP was able to where GP could not size distribution
liveborn provide information provide information for complete group
offspring Males Females Males Females Males Females Both
0 27 63 10 8 37 71 108
1 15 14 5 3b 20 17b 37b
2 13 20 5 3 18 23 41
3 5 4 2 1 7 5 12
4 1 2 0 0 1 2 3
5 0 1 0 0 0 1 1
Total 61 104 22 15 83 119 202
aThe numbers in this column are calculated by assuming that the 22 male patients for
whom family size information was not obtained from the general practitioner had family
sizes in similar proportions to those male patients for whom information was provided.
Similarly for the female patients, the one case ofretinoblastoma in a child born to such a
mother being added separately and not included in thesecalculations. bIncludes family with
one child with retinoblastoma born to a survivor classified as having sporadic unilateral
retinoblastoma.216 G.J. DRAPER et al.
As with the study of other pregnancies among parents of
children with retinoblastoma we thought it possible that
survivors of retinoblastoma might have an increased miscar-
riage or stillbirth rate. However there was no evidence of
such an increase.
Discussion
A considerable range of figures has been published concern-
ing the proportions of unilateral/bilateral cases and here-
ditary/non-hereditary cases of retinoblastoma. On the basis
of the large numbers of cases of retinoblastoma presented in
this paper diagnosed between 1962 and 1985, a period for
which we believe we have good ascertainment, and where the
cases have been followed up through family doctors and
clinicians to verify the diagnosis and family history, we sug-
gest that the distribution of cases in Britain is as follows.
Bilateral cases represent 40% of the total number; of these
28% have a family history at the time of diagnosis. Of the
60% of cases which are affected unilaterally, 7% have a
previous family history. In all, 15% of cases have a family
history of retinoblastoma at the time of diagnosis. Our sug-
gested proportions of 44% hereditary and 56% non-here-
ditary cases may be subsequently affected by further cases of
retinoblastoma appearing in the families of those who on
present information are placed in the sporadic non-hereditary
category.
The proportion of bilaterally affected cases in this study
(40%) is higher than that reported in many other studies.
Some studies are subject to selection bias and not too much
reliance should be placed on the proportions quoted. How-
ever, the Surveillance, Epidemiology and End Results (SEER)
study of children's cancer in the United States includes 220
cases of retinoblastoma ascertained from nine population
based registries, and the proportion of bilateral cases quoted
in this study was only 25% (Tamboli et al., 1990). It is
possible that some of the cases originally ascertained as
unilateral in this study later developed tumours in the other
eye. Among 550 cases ascertained in the Netherlands, 31%
were found to be bilateral (Schappert-Kimmijser et al., 1966),
and in a study of 899 cases of retinoblastoma in France, 34%
were bilateral (Bonaiti-Pellie, 1976).
For comparison with our figure of 44% for the proportion
of all hereditary cases, Der Kinderen et al. (1988) found that
36% of the total of 403 cases in the Netherlands retinoblas-
toma registry diagnosed between 1945 and 1970 were heredi-
tary. A subgroup of 598 patients in Bonaiti-Pellie's study
where a complete family history was obtained showed a pro-
portion of 40% of patients to have hereditary retinoblastoma.
It has been suggested that the proportion of hereditary
cases in the population will increase with improved survival
(Vogel, 1979). We have not observed this in our figures (see
Table I), but are not able to obtain reliable population based
data for the years before 1962.
Age at diagnosis
The data on average age at diagnosis in Table II confirm and
extend those from previous studies. It is well recognised that
patients with the hereditary form of retinoblastoma tend to
be diagnosed earlier than those with the non-hereditary form
and that bilateral cases tend to be diagnosed earlier than
unilateral ones; since bilateral cases are hereditary and uni-
lateral cases mainly non-hereditary these two comparisons to
some extent overlap. In Table II we have attempted to
separate the two effects. The first two columns compare
hereditary unilateral and bilateral cases. A possible explana-
tion of the difference between bilateral and unilateral cases is
that the occurrence of bilateral disease may be an indication
that the individual or family is more susceptible, or more
exposed to mutagenic agents, than those where the disease is
unilateral; retinoblastoma would be expected to develop ear-
lier in the former. For hereditary cases without a family
history (new germ cell mutations) the bilateral cases are
diagnosed later than those with a family history; this may
simply be a consequence of the fact that these patients would
not have had the regular eye examination that those with a
family history have.
Non-hereditary unilateral cases are on average diagnosed
later than any of the other groups. This is well recognised
and can be predicted as a consequence of the hypothesis that
such cases have to accumulate two somatic mutations rather
than one before retinoblastoma develops (Knudson, 1978).
Risks to siblings
When parents are known to be carriers of the retinoblastoma
gene, the risk to their children of inheriting the mutated gene
is 50%. The risk that the gene is expressed as retinoblastoma
is commonly accepted to be 90%, though this may be lower
if the parent is unilaterally affected. Using life-table methods
as described in the Section 'Sibships of retinoblastoma cases:
Results (i)', to allow for varying periods of follow-up, the
estimated risk for the siblings of bilaterally affected cases in
such families is 44.8%, corresponding to a penetrance of
89.6%. This compares with the generally accepted estimate of
90%. The life-table estimate of the risk of retinoblastoma for
the siblings ofunilaterally affected children in such families is
30%, giving an estimated penetrance of 60%.
When a new case of retinoblastoma appears in a family
with no previous family history of the disease, parents are
naturally anxious to know the risk that a subsequent child
might be affected. The difficulty in estimating this risk arises
from the different ways in which the retinoblastoma may
have arisen. It may be the result of somatic mutations in the
affected child or of a new mutation affecting a single parental
germ cell; there is no increased risk to other siblings in either
of these cases. Alternatively it may have been the result of an
unrecognised old germ cell mutation or ofgonadal mosaicism
in a parent. The risk to the siblings of sporadic cases is an
average of the separate risks for these various types of
family. This average risk has been assessed by Vogel (1979)
as 6% after the birth of a bilateral sporadic case and 1%
after the birth of a unilateral sporadic case. From our study
of families where, apart from the index child, there was no
family history of retinoblastoma, we conclude that if there is
just one affected child and no unaffected children in the
family the risk that the next child will be affected is 2% for
siblings of a bilaterally affected child and about 1% for
siblings of a unilaterally affected child. As explained in the
Section 'Sibships of retinoblastoma cases: Results (ii)' and
'Appendix A3', these risks are lower if there are also some
unaffected children in the family. This latter point is referred
to but not discussed by Vogel whose estimates appear to be
averages taken over all sibship sizes. Taking this into ac-
count, our estimate for siblings of sporadic unilateral cases is
rather lower than Vogel's; allowing for the degree of uncer-
tainty in the estimates they are consistent with each other.
Our estimate for siblings of sporadic bilateral cases is con-
siderably lower than Vogel's, particularly since it again re-
lates to a sibling ofan only, affected, child (the type offamily
for which the estimated risk to a subsequent child is highest)
while Vogel's is an average for different family sizes.
Risks to offspring
In this part of the study, the likelihood of passing on the
mutated retinoblastoma gene to their children is assumed to
be the same for both old germ cell and new germ cell
(sporadic bilateral) cases of retinoblastoma. Among 75 chil-
dren born to the 44 survivors with the hereditary form of
retinoblastoma who had liveborn children 32 developed retin-
oblastoma. Using life-table methods it can be estimated that
the proportion developing retinoblastoma by age 6 years is
43.5%, giving a penetrance of 87%. Again this is very close
to the usual assumption of a 90% penetrance.
The analysis in the Section 'Offspring of retinoblastoma
cases: Results' and 'Appendix Section A4', suggests that for
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blastoma the risk is about 1%, the proportion of unilateral
sporadic cases who are in fact carrying the retinoblastoma
gene being estimated as about 2%. This value updates the
previous estimate, given in Hawkins et al. (1989), which was
based on an earlier analysis of a subset of the cases in the
present paper. The estimated risk to subsequent children
after the birth of an affected child is of course the same as
that for other parents with hereditary retinoblastoma. Again,
for each unaffected child born to a possible carrier the
estimated probability that subsequent children will be affec-
ted decreases.
For unilateral sporadic cases, Vogel (1979) has suggested
that between 10% and 12% of such cases are caused by germ
cell mutations and therefore that about 5% of their children
may be affected with retinoblastoma. Vogel bases his esti-
mate, which is the one nearly always quoted for genetic
counselling, on the joint results from seven separate studies,
the largest study (Schappert-Kimmijser et al., 1966), giving a
particularly high rate of affected children in the families of
survivors from unilateral sporadic retinoblastoma. If the
selection of cases included in some of these seven studies was
biased this could lead to an overestimate of the risk: such
bias could arise for instance if unilateral sporadic probands
were included in a series after being ascertained through an
affected offspring. Again, if inadequate family histories were
obtained cases could be wrongly classified as sporadic.
Non-ocular tumours
It is well known that survivors of hereditary retinoblastoma
have a greatly increased risk of developing a variety of other
tumours (Draper et al., 1986; Sanders et al., 1989) and it has
been suggested that there may be an increased risk even
among unaffected family members. In the present study we
found two cases of childhood cancer, one osteosarcoma and
one acute lymphoblastic leukaemia among 1,246 unaffected
siblings in retinoblastoma families, both occurring among the
698 siblings of sporadic non-hereditary cases. This represents
a rather higher incidence than that found in the general
population but cannot necessarily be considered as evidence
of an increased risk in non-carriers, particularly as it seems
reasonable in view of the well known association between
retinoblastoma and osteosarcoma to speculate that the case
of osteosarcoma might have arisen in a child with unex-
pressed retinoblastoma.
In the study of offspring, one of the 217 children identified
in the follow-up studies developed a testicular teratoma.
This, together with a case of a sib of a patient with sporadic
unilateral retinoblastoma who developed a teratoma of the
testis (included in the registry but not in this study) raises the
question of whether there is a real association between these
two conditions. We have also noted that a child born to a
survivor from sporadic unilateral retinoblastoma died from
neuroblastoma. We do not know of any previous reference to
an association between these two neoplasms and this may
well be a chance finding.
Genetic counselling
The results of this paper are obviously relevant to problems
of genetic counselling. For patients with hereditary retino-
blastoma our findings agree with the generally quoted risk of
retinoblastoma to their offspring of 45% - arising from a
50% risk of inheriting the retinoblastoma gene, together with
a penetrance of 90%. The risks to various types of relative
can be calculated in the same way as for any dominant gene;
see for example the discussion in Harper (1988) Chapter 2.
The risks for patients with sporadic unilateral retinoblas-
toma and their relatives appear to be much smaller than the
estimates quoted in earlier papers. As explained above most
of these estimates seem to be based on Vogel's (1979) review
and there is some uncertainty about the selection of cases in
the series on which he bases his estimates. Our estimate of
the probability that a unilateral sporadic case is in fact a
gene carrier is about 2%, perhaps higher if the case has no
siblings, and decreasing as the number of unaffected siblings
increases. The probability that the gene will be transmitted to
the children of such patients is about 1%. The estimated risk
for a sibling of a unilateral sporadic case, when there are no
other siblings, is similar. Again this risk decreases as the
number of unaffected siblings increases. For siblings of pa-
tients with bilateral retinoblastoma our estimate of the risk is
about 2%, less if there are already unaffected siblings; this is
lower than that of Vogel, which was based on the study by
Briard-Guillemot et al. (1974), of about 6%. It is not clear
whether the substantial difference between these estimates is
due to the fact that both are rather imprecise or whether in
the Briard-Guillemot study some family histories were missed
and the cases wrongly classified as sporadic.
Genetic counselling for other relatives of these patients can
again be based on standard methods for such diseases
(Harper, 1988, Chapter 2).
With recent developments in molecular genetics it is of
course possible, in certain situations, to make considerably
better risk estimates:
(i) Where at least two family members are affected it is
possible, using restriction fragment length polymorphisms
(RFLPs) to apply standard methods of genetic linkage ana-
lysis to identify gene carriers with a high degree of certainty;
the range of RFLPs now available mean that the great
majority of families will be informative using this method
(Wiggs et al., 1988). These techniques have been applied both
prenatally and postnatally (Onadim et al., 1990).
(ii) Even for sporadic cases it may be possible to distin-
guish between hereditary and non-hereditary cases using the
approach described by Yandell et al. (1989) which involves
the direct identification of point mutations in the retinoblas-
toma gene and compares tumour cells with constitutional
cells.
Cowell (1991) in a review of the molecular genetics of
retinoblastoma stated that identification of all gene carriers
in retinoblastoma families will soon be possible. This would
mean that the frequent ophthalmological examinations under
anaesthetic of all children of affected parents and other
relatives of retinoblastoma patients would no longer be
necessary, and clinical resources could be concentrated on
patients who are carriers.
This paper is based on information provided by cancer registries,
hospital consultants and family doctors in Britain. We would like to
thank them, and are especially grateful to the parents of children
included in this study who agreed to be interviewed and to give
information about their families; the data from some of these inter-
views was kindly made available to us by the staff of the Oxford
Survey of Childhood Cancer in Birmingham. The Office of Popula-
tion Censuses and Surveys, the Information and Statistics Division
of the Common Services Agency of the Scottish Health Service, the
Registrar General for Scotland and Regional Cancer Registries all
provided notifications of retinoblastoma cases, and we are grateful to
them. We would also like to thank Dr M. Jay and Dr J.E. Kingston
of Moorfields and St Bartholomew's Hospitals for information pro-
vided about patients and their families. We are grateful to Mrs K.
Bunch, Mrs E. Mowat, Mrs E. Roberts and Mr M. Loach for help
with setting up the database, collection of data and computer cal-
culations.
We are grateful to one of the referees for suggestions on the
analysis of the risks to siblings and for pointing out that our results
had implications for the estimation of the proportions of non-
penetrant cases of hereditary retinoblastoma.
The Childhood Cancer Research Group is supported by the
Department of Health and the Scottish Home and and Health
Department. The work of collecting family data was also supported
in part by the Cancer Research Campaign.
APPENDIX: STATISTICAL METHODS
In Section Al, A2, A3 we give details of the statistical methods used
to estimate the risks to siblings of affected cases and to offspring of
parents known to have the hereditary form of retinoblastoma. In
Section A4 we explain the method used to estimate the proportion of
hereditary cases among sporadic unilateral cases, on the basis of the
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Al Risks to offspring of hereditary cases
For simplicity we discuss first the estimation of the risk for offspring
of hereditary cases. Virtually all cases of retinoblastoma become
apparent by age 10 years; thus if all offspring were followed up to
age 10 the proportion of affected cases would be simply the ratio of
affected cases to total offspring. Since in practice the length of
follow-up varies it is necessary to use actuarial, or life-table, methods
in estimating the risk (see e.g. Peto et al., 1976; 1977). This method is
routinely used in clinical trials where patients are followed-up for
differing lengths of time and where the length of survival to death or
relapse is allowed for in the analysis. The essence of the method is
that if we are interested in, say, mortality 5 years after treatment we
cannot classify patients who have only been followed up for 3 years
and are alive at that time; but they do, for the first 3 years,
contribute to the denominator of those at risk for the first 3 years,
and therefore must be taken into account in calculating the risk up
to that point since this affects the risk at 5 years. Similarly, in the
present analysis, offspring known to be alive at 3 years (but then lost
to follow-up) contribute to the denominators ofpersons at risk up to
that age, but not thereafter. In Table VI we give the actuarial
estimates of the proportions of offspring of hereditary cases who
developed retinoblastoma by age 1 year and by age 6 years. (The
estimates of standard errors in this table are the conservative ones
suggested by Peto et al., 1977, i.e. they are likely to be overes-
timated.) Since, as shown in Table II, about 99% of affected
hereditary cases develop the disease by age 5, the risk by age 6 is
almost equivalent to the total risk.
A2 Risks to siblings of affected cases in families with a previous
family history
For the risks to siblings in these families it is necessary to take into
account the fact that in some of the families with more than one
affected child, the sibship was ascertained independently through two
or more of these affected children. (This point is discussed in, for
example, Cavalli-Sforza & Bodmer, 1971). If, for instance, the family
contains two independently ascertained affected siblings A and B,
and two unaffected siblings C and D the family contributes twice to
the analysis as follows: first, regarded as siblings of A there are three
siblings, B, C and D at risk, one of whom, B is affected; secondly,
regarded as siblings of B, sib A is affected, C and D are unaffected.
With this interpretation of the at-risk population the analysis pro-
ceeds in the same way as that for the offspring described above. The
standard errors calculated from the life-table analysis (though again
calculated according to the conservative method which overestimates
the error of the usual life-table method) do not take the double
ascertainments into account and this will lead to an underestimation.
By analogy with the situation where all cases are identified during
the period of follow-up, i.e. where actuarial methods are not neces-
sary, it seems likely that the standard error is not more than 40%
greater than the value quoted here (Cavalli-Sforza & Bodmer,
pp. 856-7).
A3 Risk to siblings of affected cases in families where there is not
known to be a previous family history
As explained in the Section 'Sibships of retinoblastoma cases: Results
(ii)', the estimation of the risk to siblings in these families is com-
plicated by the fact that the families are actually a mixture of types -
those where there is an old germ cell mutation (or gonadal mos-
aicism) and those where there is not. The affected children in the
latter families may have retinoblastoma following a first mutation
which affected either a parental germ cell or a somatic cell in the
child: in either case there is no increased risk for sibs. If there are
two affected children the recurrence risk for further children is
probably the same as for families with known heritable retinoblas-
toma. On the other hand, for families with only one affected child
the estimated recurrence risk depends on the number of unaffected
children in the family: the estimates required for genetic counselling
must take this into account. The risks depend on the proportions of
families with unrecognised old germ cell mutations among those
where one child has retinoblastoma. For genetic counselling, we need
to estimate the probabilities of a second case occurring in families of
specified sizes, given that there is one child affected and that the
remainder are unaffected. We assume that these probabilities may
depend on whether the affected child has bilateral or unilateral
retinoblastoma. For instance, we require for a family of size s,
including one child with bilateral retinoblastoma, and no family
history, an estimate of the risk that the next child will be affected.
Such probabilities could in principle be estimated empirically from
the data on families of different size, but in practice the numbers of
cases available are far too small for this approach; the method
described here makes use of all the data to estimate the probability,
x,, that for a family with one sporadic case and no unaffected cases
the family is carrying an old germ cell mutation (in which we include
the possibility of gonadal mosaicism). The other probabilities of
interest can be derived from xl. For a family with two children of
whom one is a sporadic case and one is unaffected let x2 be the
probability that there is an old germ cell mutation. In general denote
this probability by x, if one of a family of s children is affected. Let p
be the probability of an affected case occurring if the family is
carrying an old germ cell mutation. On the basis of the results given
in Table IV we assume that, for such families, if there is already an
affected case, p = 0.45 if the case is bilateral and 0.3 if it is unilateral;
let q = 1 - p.
Obviously, for a family with one out of s children affected the
probability that there is not an old germ cell mutation is 1 - x,. In
this case the probability that the next child will not be affected is,
say, r, which is almost equal to unity.
The probability x, does not depend on which one of the s children
is affected and is, in particular, the probability that there is an old
germ cell mutation, given that one of the first s - 1 children is
affected and the Sth one is not.
Then, by Bayes' Theorem
s = qxs.l
qxs.. + r(l-xs.)
From previous data and from the present study xi is small and r is
very nearly equal to one; thus
s qx -I
Xs..q .XI
The probability, y, that the (s + I)th child will be affected is px,
and, obviously, y, qS - ly1- If there are ns families with s children of
whom one is affected and who go on to have a further child, and if
as of these children are affected we may estimate y, by as/n, and y1 by
as/(nsqs-), i.e. we can obtain an estimate of y1 for each value of s.
The variances of these estimates are {var (a,))/(ns2q2s 2) and, taking
as as a Poisson variable, this is approximately as/n,2q2s- 2. The
expected value of this expression is y1/n,qs ', i.e. the variances for
families of different sizes are approximately inversely proportional to
nqs - and thus the combined estimate for y, using data from all the
families is
y, = a5/En,qs-'
y, is the estimated risk for subsequent siblings in families with one
affected child and no unaffected ones. For a family of size s with one
affected child and s -1 unaffected siblings the risk ys = qS-'y1 can be
estimated, given y, and q.
For families of size 1, 2, 3, . s, and just one affected case, the
proportions with unrecognised germ cell mutations are x, = y,/p, qx1,
q2xi qS
-Ixi.
A4 Estimation of proportion of hereditary cases among sporadic
unilateral retinoblastoma cases
There is at present no direct and generally applicable method of
classifying sporadic unilateral retinoblastoma cases as hereditary and
non-hereditary though advances in molecular genetics may soon
make this possible. If we wish to estimate the proportion of gene-
carriers in this group it is necessary to use information on their
offspring. The method of estimation described below takes into
account the fact that, for instance, a survivor with four unaffected
children is less likely to be a gene carrier than one for whom there is
only one unaffected child.
We denote the unknown proportion of unilateral sporadic cases
that actually have the hereditary form by A. This parameter and its
standard error may be estimated using the method of maximum
likelihood.
Let T be the total number of families in which one parent has
unilateral sporadic retinoblastoma, n be the total number of children
in a family, and r the number with retinoblastoma. Let u be the
probability of retinoblastoma developing in a child if a parent is a
gene carrier and v the probability otherwise. We assume that all
children are followed up at least to the age by which all retinoblas-
tomas will be diagnosed.
The likelihood of the observed data is
H (n) [A. ur (1
_ U)nr + (l_)vr(l -V)n -
the product being taken over the values
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The log likelihood L is
L = [log (n) + log (f+ gA)]
where f= vr (1 -V)n-r
and g = ur(1 - u)-r vr( - V)n -r
The maximum likelihood estimate of A, i.e. the estimated proportion
of unilateral sporadic cases that are hereditary, is obtained by setting
dL
=0 and solving this equation for A:
dL
= (h +A)', where h =f/g
and the summation is taken over the values of n and r for the T
families.
For the present study the values of the n are shown in Table VII;
all of the values of r, except one, are zero; in one family r = n = 1.
Assuming the risk to the offspring is the same for unilaterally
affected parents as it is for bilaterally affected parents, u = 0.45. The
risk in the general population, v, is less than 1 in 20,000 and 1-vc.1.
For families where r = 0, h - 11/(0.55n - 1)
For the family with r= n = 1, h 0.
Table VII gives estimates of the numbers of families with 1, 2, 3, 4
and 5 children. Excluding the one affected child these numbers are
36, 41, 12, 3 and I respectively.
Writing kn= 1/(0.55n-1), the estimated value of A, the proportion
of unilateral sporadic cases that are hereditary is the solution of
1/A + 36/(k, +A) + 41/(k2 +A) + 12/(k3+ A) + 3/(k4+A) + 1/(k5 +A) = 0.
Solving this equation gives an estimate of 0.0169 for the value of
A, with an estimated standard error, using the usual maximum
likelihood method, of 0.0168. This standard error and that in the
next paragraph are based on small numbers and it seems unlikely
that the usual normal approximation is valid; they should be re-
garded as giving only a general idea of the precision of the estimates.
If we assume that the risk to the offspring of unilaterally affected
parents with hereditary retinoblastoma is the same as that for the
siblings of unilateral hereditary cases then, from the first part of
Table IV, u = 0.3. Repeating the above calculations with this value
of u gives an estimate of 0.0231 with a standard error of 0.0230.
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